Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 1/20 | 0.41 |
| ▸ | FNTB | P49356 | 1/20 | 0.41 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.40 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.40 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.40 |
| ▸ | CTSC | P53634 | 3/20 | 0.39 |
| ▸ | GABRR1 | P24046 | 3/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.31 |
| ▸ | TERT | O14746 | 1/20 | 0.31 |
| ▸ | GSR | P00390 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2259056 | 0.87 | FNTA (0.42) | FNTAFNTBGLRA1SLC6A9OR51E2 | |
| SCHEMBL31074340 | 0.85 | FNTA (0.34) | FNTAFNTBCTSCTHRBRECQL | |
| SCHEMBL7864321 | 0.79 | CTSC (0.37) | GLRA1SLC6A9OR51E2CTSCMMP2 | |
| SCHEMBL11468148 | 0.79 | CTSC (0.45) | CTSCMMP2CNR2 | |
| SCHEMBL10703635 | 0.78 | FNTA (0.41) | FNTAFNTBOR51E2TGFBR1ALDH1A1 | |
| SCHEMBL11445805 | 0.78 | FNTA (0.41) | FNTAFNTBALDH1A1THRBRECQL | |
| SCHEMBL24130617 | 0.77 | GNPAT (0.39) | GLRA1SLC6A9OR51E2CTSCTGFBR1 | |
| SCHEMBL3145911 | 0.77 | SMN1; SMN2 (0.50) | CTSCGABRR1ALDH1A1 | |
| SCHEMBL783990 | 0.77 | SMN1; SMN2 (0.50) | CTSCGABRR1ALDH1A1 | |
| SCHEMBL564562 | 0.77 | SMN1; SMN2 (0.50) | CTSCGABRR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1618117-B1 | TUMOR SELECTIVE AND BIODEGRADABLE POLYPHOSPHAZENE-PLATINUM(II) CONJUGATE ANTITUMOR AGENT, AND PREPARATION METHOD THEREOF | TRUSTEES EWHA WOMANS UNIVERSIT (KR) | 2008-04-23 | — | — | EP | claimed |
| EP-1618117-A4 | TUMOR SELECTIVE AND BIODEGRADABLE POLYPHOSPHAZENE-PLATINUM(II) CONJUGATE ANTITUMOR AGENT, AND PREPARATION METHOD THEREOF | TRUSTEES EWHA WOMANS UNIVERSIT (KR) | 2007-04-11 | — | — | EP | claimed |
| EP-1618117-A1 | TUMOR SELECTIVE AND BIODEGRADABLE POLYPHOSPHAZENE-PLATINUM(II) CONJUGATE ANTITUMOR AGENT, AND PREPARATION METHOD THEREOF | Board of Trustees, Ewha Womans University (KR) | 2006-01-25 | — | — | EP | claimed |
| US-6951953-B2 | Tumor selective and biodegradable polyphosphazene-platinum(II) conjugate antitumor agent, and preparation method thereof | EWHA WOMANS UNIVERSITY (KR) | 2005-10-04 | — | — | US | claimed |
| WO-2004096820-A1 | TUMOR SELECTIVE AND BIODEGRADABLE POLYPHOSPHAZENE-PLATINUM(II) CONJUGATE ANTITUMOR AGENT, AND PREPARATION METHOD THEREOF | BOARD OF TRUSTEES, EWHA WOMANS UNIVERSITY (KR) | 2004-11-11 | — | — | WO | claimed |
| US-20040219127-A1 | Tumor selective and biodegradable polyphosphazene-platinum(II) conjugate antitumor agent, and preparation method thereof | EWHA WOMANS UNIVERSITY (KR) | 2004-11-04 | — | — | US | claimed |
| EP-1618117-B1 | TUMOR SELECTIVE AND BIODEGRADABLE POLYPHOSPHAZENE-PLATINUM(II) CONJUGATE ANTITUMOR AGENT, AND PREPARATION METHOD THEREOF | TRUSTEES EWHA WOMANS UNIVERSIT (KR) | 2008-04-23 | — | — | EP | disclosed |
| EP-1618117-A4 | TUMOR SELECTIVE AND BIODEGRADABLE POLYPHOSPHAZENE-PLATINUM(II) CONJUGATE ANTITUMOR AGENT, AND PREPARATION METHOD THEREOF | TRUSTEES EWHA WOMANS UNIVERSIT (KR) | 2007-04-11 | — | — | EP | disclosed |
| EP-1618117-A1 | TUMOR SELECTIVE AND BIODEGRADABLE POLYPHOSPHAZENE-PLATINUM(II) CONJUGATE ANTITUMOR AGENT, AND PREPARATION METHOD THEREOF | Board of Trustees, Ewha Womans University (KR) | 2006-01-25 | — | — | EP | disclosed |
| US-6951953-B2 | Tumor selective and biodegradable polyphosphazene-platinum(II) conjugate antitumor agent, and preparation method thereof | EWHA WOMANS UNIVERSITY (KR) | 2005-10-04 | — | — | US | disclosed |
| WO-2004096820-A1 | TUMOR SELECTIVE AND BIODEGRADABLE POLYPHOSPHAZENE-PLATINUM(II) CONJUGATE ANTITUMOR AGENT, AND PREPARATION METHOD THEREOF | BOARD OF TRUSTEES, EWHA WOMANS UNIVERSITY (KR) | 2004-11-11 | — | — | WO | disclosed |
| US-20040219127-A1 | Tumor selective and biodegradable polyphosphazene-platinum(II) conjugate antitumor agent, and preparation method thereof | EWHA WOMANS UNIVERSITY (KR) | 2004-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040219127-A1 | Tumor selective and biodegradable polyphosphazene-platinum(II) conjugate antitumor agent, and preparation method thereof | PHOSPHO1, FOLR1, PCNA | FNTA 3576/4885FNTB 2554/4885GLRA1 886/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.